English
Leave Your Message
  • Clinical Service Center

    Our mission is on: Prioritizing Service Quality, Serving Pharma Innovation, Advancing Healthy Humanity.

Clinical Service Center Co., Ltd. (CSC) is a comprehensive Contract Research Organization providing full-services for global biopharmaceutical and medical apparatus enterprises, including clinical operations, regulatory affairs, medical strategy and writing, medical monitoring, data management and statistical analysis, pharmacovigilance and call center services, quality assurance and audit, marketing strategy, consulting and training services etc.

Positioned as a China-based CRO with a global reach, CSC has transformed into a fully-fledged clinical research enterprise, boasting a workforce of 1000+ professionals accumulated over the past 15 years. With a solid foundation, CSC possesses extensive experience and service networks that span across North America, Europe, and the Asia-Pacific region.

CSC headquarter is located in Suzhou, China, with other 12 physical offices addressed respectively in Shanghai, Beijing, Guangzhou, Tianjin, Chengdu, Xi'an, Shenyang, Nanjing and Taipei. Our dedicated staff is stationed in key urban centers to ensure seamless operations and efficient client supports.

Furthermore, CSC global reach extends through subsidiaries (or branches) established in pivotal international locations, e.g., the United States, the United Kingdom, Canada, Australia, Hong Kong, Singapore, and various other regions. This extensive footprint enables us to cater to the diverse needs of our clients on a global scale, fostering collaboration and excellence in our services.

Clinical Service Center has been serving the fields of oncology, immunity, endocrinology, cardiovascular, blood, respiratory, ophthalmology, liver diseases and so on. More than 90% of our clinical projects are categorized as innovative drugs. With clinical trial experiences accumulated for many years, we help our clients completing the regulatory submission processes involving in IND applications and NDA registrations with many advanced products, such as PD-1, CAR-T, double antibody, CD47, and stem cell drugs etc.

We have so far delivered more than 1000 integrated clinical services for global pharmaceutical companies, accelerating their products access to worldwide markets effectively, as well as helping maximize their return on investment during the pharmaceutical R&D process. Through the whole development journey, CSC has also been recognized as one of leading CROs in China due to our services driven by CSC core value and mission.   

CSC global teams have always worked with a full of passionate and devoted spirits, whose core members with intensive experiences in multinational companies are adhering to their proficiency and commitment to excellence. Some of CSC professionals are honorary to be engaged as the special-invited experts by NMPA (National Medical Products Administration), in various national compilation of laws and regulations in areas to biomedical and high-end medical devices.  

In terms of social responsibility, CSC contributes proactively to talent cultivation, co-established a pioneering Master's degree on Clinical Trial Methodology of Drugs with China Pharmaceutical University. This college-enterprise cooperation stands as an evident of our dedication to advancing knowledge and expertise in this field.  Additionally, we have jointly launched various collaborative programs for synergistically scientific investigation and professional talents cultivation  with Xi 'an Jiaotong University, Suzhou University, Nanjing Medical University and other prestigious medical universities in China.

Enterprise Partial Honors

hubddxhy
  • 2014

    2014 - Awarded as an Excellent Team in the Annual Clinical Trial Quality Control Evaluation by the Cancer Hospital of the Chinese Academy of Medical Sciences.

  • 2015

    2015 - Awarded as an Excellent Team in the Annual Clinical Trial Quality Control Evaluation by the Cancer Hospital of the Chinese Academy of Medical Sciences.

  • 2016

    2016 – CSC Subsidiary, Meta Clinical Technology Co., Ltd. achieved the first prize in the 2016 China-US Pharmaceutical and Medical Entrepreneurship Competition, Northwest Division, and the Xi'an Biomedical and Health Innovation Entrepreneurship Competition.2016 - Awarded as an Excellent Team in the Annual Clinical Trial Quality Control Evaluation by the Cancer Hospital of the Chinese Academy of Medical Sciences.2016 - After rigorous evaluation, Clinical Service Center Co., Ltd. became a joint training/educational base for Master degree of Clinical Pharmacy by China Pharmaceutical University (a key university under the "211 Project").

  • 2018

    2018 - Clinical Service Center Co., Ltd. was honored as a "High-Tech Enterprise."2018 - Recognized for outstanding performance in human resources information work, awarded the title of "China's Top 100 HR Informationization Enterprises."September 2018 - Dr. Daniel Liu, Chief Scientific Officer of Clinical Service Center Co., Ltd., was invited to give a training lecture on China Laws and Regulatory Environments and Practices of Drug for health ministers at the ministries meeting of the Forum of China-Africa Cooperation by Ministry of Commerce PRC in Beijing, receiving unanimous praises from organizers and participants.October 2018 - Dr. Hualong Sun, Chief Strategic Officer and then General Manager of Meta Clinical Technology Co., Ltd. under CSC, was invited to give a lecture on data quality management and standards of medicinal products for health ministers at the ministries meeting of the Forum of China-Africa Cooperation by Ministry of Commerce PRC in Beijing, receiving high praises from experts and senior officials from various countries.

  • 2019

    2019 - Clinical Service Center Co., Ltd. became a member unit of the China Chemical Pharmaceutical Industry Association. One person was appointed as the Deputy Leader of the Early Clinical Trial Research Group, of the First Sino-Western Integrated Oncology Committee of the China Anti-Cancer Association. 7 people were appointed as members, and 1 person was appointed as a member of the first Clinical Research Committee.

  • 2020

    2020 - Subsidiary Meta (Nanjing) Clinical Technology Co., Ltd. was awarded as a "Jiangsu Province High-Tech Enterprise 2020."2020 - Clinical Service Center Co., Ltd. was honored as a finalist in the Brand List at “the 7th China Industry Influence Brand Summit”.2020 – Immune Onco awarded Clinical Service Center Co., Ltd. the "Five Years of Unity, Grateful for Your Presence" trophy.

  • 2021

    2021 - Clinical Service Center Co., Ltd. gained the Golden Horse Awards of "2021 Best Clinical CRO Enterprise (TOP10)" at the China Pharmaceutical and Biological Industry Chain-Innovation Summit.

  • 2022

    2022 - Clinical Service Center Co., Ltd. was crowned as one of the "Top 100 Chinese Brands" in the evaluation of 2022 China Life Science Enterprise Brand.2022 - Clinical Service Center Co., Ltd. received the "Outstanding Employer" awarded by the platform of 51JOB, in the 2022.2022 - Clinical Service Center Co., Ltd. was awarded the title of "High-Quality Employment Site for Graduates" by China Pharmaceutical University.2022 - Clinical Service Center Co., Ltd. Project-BCSC00124, received the "Best Supplier Award" from the sponsor Jieke Biotech.2022 - Suzhou Municipal Hospital awarded Clinical Service Center Co., Ltd. the "Sincere Cooperation Award".

  • 2023

    2023 - Clinical Service Center Co., Ltd. was honored as the "Annual Influential CRO Enterprise" in the 4th China Biopharmaceutical Industry Chain- Innovation Summit.